AMLODIPINE

✓ Medically ReviewedRxCalcium Channel BlockerAPPROVED
💡

Quick Summary

Amlodipine is a profoundly long-acting dihydropyridine calcium channel blocker used globally as a first-line agent for hypertension and chronic stable angina. It works by blocking voltage-gated L-type calcium channels in vascular smooth muscle, causing substantial peripheral arterial vasodilation and a subsequent drop in systemic vascular resistance. Unlike non-dihydropyridines, it has minimal effect on cardiac conduction or heart rate. The dominant clinical challenge is dose-dependent peripheral oedema, which is driven by precapillary vasodilation rather than fluid retention and is unresponsive to standard loop diuretics.

🔬

Drug Identity

GENERIC NAMEAmlodipine
MEDOBO IDMDBD0018
ATC CODEC08CA01
DRUG CLASSCalcium Channel Blocker
PHARMACOLOGICAL CLASSDihydropyridine Calcium Channel Blocker (CCB)
THERAPEUTIC CLASSAntihypertensive, Antianginal
THERAPEUTIC CATEGORYCardiovascular
CHEMICAL NAME3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate besylate
DRUG SOURCESynthetic
FDA APPROVAL1992
MODALITYSmall Molecule
DRUG TYPEstandard
MARKET STATUS● Approved
CORE USE TAGS
HypertensionAnginaCalcium Channel BlockerVasodilator
BRAND NAMES (GLOBAL)
NorvascIstinAmlocAmlovasStamloAmlopresAmlodacCamlodinLodipinPerindalAmlorAmlocardAmodepAsomexAmlodipine Besylate
SYNONYMS
Amlodipine besilateAmlodipine maleateAmlodipine mesylateUK-48340
📌

Indications & Uses

🎯 APPROVED INDICATIONS
  • Hypertension — alone or in combination with other antihypertensive agents in adults and children aged 6 years and older
  • Chronic Stable Angina — for symptomatic relief, alone or in combination with other antianginal agents
  • Vasospastic Angina (Prinzmetal's or Variant Angina) — as monotherapy or in combination with other antianginal drugs
  • Angiographically Documented Coronary Artery Disease — in patients without heart failure or an ejection fraction < 40%, to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure
🔬 OFF-LABEL USES
  • Raynaud's phenomenon — first-line pharmacological treatment to reduce the frequency and severity of vasospastic digital attacks
  • High-altitude pulmonary oedema (HAPE) prevention — used in susceptible individuals, though nifedipine remains the classically established dihydropyridine for this indication
  • Chilblains (Perniosis) — used to induce peripheral vasodilation and improve symptom resolution
MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current prescribing information, institutional protocols, and official clinical guidelines. Medobo is not responsible for clinical decisions made based on this content.